Liposomes as nanomedical devices

References

• BanghamADHorneRWNegative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscopeJ Mol Biol1964866066814187392
   PubMed Web of Science ®Google Scholar
• BanghamADHillMWMillerNGPreparation and use of liposomes as models of biological membranesKornEDMethods in Membrane Biology1New YorkPlenum1974168
   Google Scholar
• EtheridgeMLCampbellSAErdmanAGHaynesCLWolfSMMcCulloughJThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine2013911422684017
   PubMed Web of Science ®Google Scholar
• FeliceBPrabhakaranMPRodríguezAPRamakrishnaSDrug delivery vehicles on a nano-engineering perspectiveMater Sci Eng C Mater Biol Appl20144117819524907751
   PubMed Web of Science ®Google Scholar
• FanciullinoRCiccoliniJLiposome-encapsulated anticancer drugs: still waiting for the magic bullet?Curr Med Chem2009164361437319835568
   PubMed Web of Science ®Google Scholar
• EulissLEDuPontJAGrattonSDeSimoneJImparting size, shape, and composition control of materials for nanomedicineChem Soc Rev2006351095110417057838
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDKimelbergHKPhospholipid vesicles (liposomes) as models for biological membranes: their properties and interactions with cholesterol and proteinsProgress in Surface ScienceOxfordPergamon1973141149
   Google Scholar
• FrolovVAShnyrovaAVZimmerbergJLipid polymorphisms and membrane shapeCold Spring Harb Perspect Biol20113a00474721646378
   PubMed Web of Science ®Google Scholar
• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine2006129731517717971
   PubMed Web of Science ®Google Scholar
• BetageriGVParsonsDLDrug encapsulation and release from multilamellar and unilamellar liposomesInt J Pharm199281235241
   Web of Science ®Google Scholar
• NivenRWSpeerMSchreierHNebulization of liposomes. II. The effects of size and modeling of solute release profilesPharm Res199182172212023870
   PubMed Web of Science ®Google Scholar
• SchechterEAspects structuraux et fonctionnelsSchechterERossignolBBiochimie et Biophysique des MembranesParisDunod2002
   Google Scholar
• Hosta-RigauLZhangYTeoBMPostmaAStädlerBCholesterol – a biological compound as a building block in bionanotechnologyNanoscale201358910923172231
   PubMed Web of Science ®Google Scholar
• BitounisDFanciullinoRIliadisACiccoliniJOptimizing druggability through liposomal formulations: new approaches to an old conceptISRN Pharm2012201273843222474607
   PubMedGoogle Scholar
• MillaPDosioFCattelLPEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug deliveryCurr Drug Metab20121310510921892917
   PubMed Web of Science ®Google Scholar
• GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A198885694969533413128
   PubMed Web of Science ®Google Scholar
• AllenTMLong-circulating (Stealth) liposomes: therapeutic applicationsPuisieuxFCouvreurPDelattreJDevissaguetJPLiposomes: New Systems and New Trends in Their ApplicationsParisEditions de Santé1995125155
   Google Scholar
• Gómez-HensAFernández-RomeroJMAnalytical methods for the control of liposomal delivery systemsTrends Analyt Chem200625167178
   Web of Science ®Google Scholar
• MozafariMRJohnsonCHatziantoniouSDemetzosCNanoliposomes and their applications in food nanotechnologyJ Liposome Res20081830932718951288
   PubMed Web of Science ®Google Scholar
• WagnerAVorauer-UhlKLiposome technology for industrial purposesJ Drug Deliv2011201159132521490754
   PubMedGoogle Scholar
• BanghamADStandishMMWatkinsJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol1965132382525859039
   PubMed Web of Science ®Google Scholar
• NewRCPreparation of liposomesNewRCLiposomes: A Practical ApproachNew YorkOxford University Press1990
   Google Scholar
• SzokaFPapahadjopoulosDProcedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporationProc Natl Acad Sci U S A19787541944198279908
   PubMed Web of Science ®Google Scholar
• BatzriSKornEDSingle bilayer liposomes prepared without sonicationBiochim Biophys Acta1973298101510194738145
   PubMed Web of Science ®Google Scholar
• DeamerDBanghamADLarge volume liposomes by an ether vaporization methodBiochim Biophys Acta1976443629634963074
   PubMed Web of Science ®Google Scholar
• LaschJWeissigVBrandlMPreparation of liposomesTorchilinVWeissigVLiposomes: A Practical ApproachNew YorkOxford University Press2003
   Google Scholar
• BrunnerJSkrabalPHausserHSingle bilayer vesicles prepared without sonication physicochemical propertiesBiochim Biophys Acta19764553223311033769
   PubMed Web of Science ®Google Scholar
• KirbyCGregoriadisGDehydration-rehydration vesicles: a simple method for high-yield drug entrapment in liposomesNat Biotechnol19842979984
   Web of Science ®Google Scholar
• WoodburyDJRichardsonESGriggAWWellingRDKnudsonBHReducing liposome size with ultrasound: bimodal size distributionsJ Liposome Res200616578016556550
   PubMed Web of Science ®Google Scholar
• HopeMJBallyMBWebbGCullisPRProduction of large unilamellar vesicles by a rapid extrusion procedure – characterization of size distribution, trapped volume and ability to maintain a membrane-potentialBiochim Biophys Acta1985812556523008845
   PubMed Web of Science ®Google Scholar
• BergerNSachseABenderJSchubertRBrandlMFilter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristicsInt J Pharm2001223556811451632
   PubMed Web of Science ®Google Scholar
• MacDonaldRCMacDonaldRIMencoBPTakeshitaKSubbaraoNKHuLRSmall volume extrusion apparatus for preparation of large, unilamellar vesiclesBiochim Biophys Acta199110612973031998698
   PubMed Web of Science ®Google Scholar
• BachmannDBrandlMGregoriadisGPreparation of liposomes using a mini-lab 8.30 H high-pressure homogenizerInt J Pharm1993916974
   Web of Science ®Google Scholar
• LaouiniAJaafar-MaalejCLimayem-BlouzaISfarSCharcossetCFessiHPreparation, characterization and applications of liposomes: state of the artJ Colloid Sci Biotechnol20121147168
   Google Scholar
• StoneHAStroockADAdjariAEngineering flows in small devices: microfluidics toward a lab-on-a-chipAnnu Rev Fluid Mech200436381411
   Web of Science ®Google Scholar
• WhitesidesGMThe origins and the future of microfluidicsNature200644236837316871203
   PubMed Web of Science ®Google Scholar
• YuBLeeRJLeeLJMicrofluidic methods for production of liposomesMethods Enzymol200946512914119913165
   PubMed Web of Science ®Google Scholar
• HoodRRVreelandWNDeVoeDLMicrofluidic remote loading for rapid single-step liposomal drug preparationLab Chip2014143359336725003823
   PubMed Web of Science ®Google Scholar
• TarabellaGBalducciAGCoppedèNLiposomes sensing and monitoring by organic electrochemical transistors integrated in microfluidicsBiochim Biophys Acta201318304374438023295972
   PubMed Web of Science ®Google Scholar
• LasicDDMagnetic resonance methods in the studies of liposomesBull Magn Reson199113313
   Google Scholar
• OstrovskyNLiposome size measurements by photon correlation spectroscopyChem Phys Lipids1993644556
   Web of Science ®Google Scholar
• PalmerAFWingertPNickelsJAtomic force microscopy and light scattering of small unilamellar actin-containing liposomesBiophys J2003851233124712885667
   PubMed Web of Science ®Google Scholar
• Grabielle-MadelmontCLesieurSOllivonMCharacterization of loaded liposomes by size exclusion chromatographyJ Biochem Biophys Methods20035618921712834977
   PubMedGoogle Scholar
• MoonMHGiddingsJCPharmJSize distribution of liposomes by flow field-flow fractionationJ Pharm Biomed Anal1993119119208305595
   PubMed Web of Science ®Google Scholar
• RuoziBBellettiDTombesiAAFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative studyInt J Nanomedicine2011655756321468358
   PubMed Web of Science ®Google Scholar
• FrederikPMHubertDHCryoelectron microscopy of liposomesMethods Enzymol200539143144815721395
   PubMed Web of Science ®Google Scholar
• JassJTjärnhageTPuuGAtomic force microscopy imaging of liposomesMethods Enzymol199336719921314611066
   PubMedGoogle Scholar
• RuoziBTosiGForniFAtomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomesEur J Pharm Sci200525818915854804
   PubMed Web of Science ®Google Scholar
• RuysschaertTMarqueADuteyratJLLesieurSWinterhalterMFournierDLiposome retention in size exclusion chromatographyBMC Biotechnol200510511
   Google Scholar
• KorgelBAVan ZantenJHMonbouquetteHGVesicle size distributions measured by flow field-flow fractionation coupled with multiangle light scatteringBiophys J199874326432729635780
   PubMed Web of Science ®Google Scholar
• MohanANarayananSSethuramanSKrishnanUMNovel resveratrol and 5-fluorouracil coencapsulated in pegylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinomaBiomed Res Int2014201442423925114900
   PubMed Web of Science ®Google Scholar
• StormGRoerdinkFHSteerenbergPAde JongWHCrommelinDJInfluence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor modelCancer Res198747336633723581073
   PubMed Web of Science ®Google Scholar
• McIntoshTJThe effect of cholesterol on the structure of phosphatidylcholine bilayersBiochim Biophys Acta19785134358718889
   PubMed Web of Science ®Google Scholar
• CullisPRHopeMJThe bilayer stabilizing role of sphingomyelin in the presence of cholesterol: a 31P NMR studyBiochim Biophys Acta19805975335427378401
   PubMedGoogle Scholar
• Defrise-QuertainFChatelainPDelmelleMModel studies for drug entrapment and liposome stabilityGregoriadisGLiposome TechnologyBoca Raton (FL)CRC1984117
   Google Scholar
• AllenTMMehraTHansenCChinYCStealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosineCancer Res199252243124391568213
   PubMed Web of Science ®Google Scholar
• FahrAvan HoogevestPMaySBergstrandNLeighMLTransfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug deliveryEur J Pharm Sci20052625126516112849
   PubMed Web of Science ®Google Scholar
• MayerLDBallyMBCullisPRUptake of adriamycin into large unilamellar vesicles in response to a pH gradientBiochim Biophys Acta19868571231263964703
   PubMed Web of Science ®Google Scholar
• ForssenEAMalé-BruneRAdler-MooreJPFluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissueCancer Res199656206620758616852
   PubMed Web of Science ®Google Scholar
• JohnstonMJEdwardsKKarlssonGInfluence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulationsJ Liposome Res20081814515718569449
   PubMed Web of Science ®Google Scholar
• DrummondDCNobleCOGuoZHongKParkJWKirpotinDBDevelopment of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategyCancer Res2006663271327716540680
   PubMed Web of Science ®Google Scholar
• ZhigaltsevIVWintersGSrinivasuluMDevelopment of a weak-base docetaxel derivative that can be loaded into lipid nanoparticlesJ Control Release201014433234020202473
   PubMed Web of Science ®Google Scholar
• ZamboniWCConcept and clinical evaluation of carrier mediated anticancer agentsOncologist20081324826018378535
   PubMed Web of Science ®Google Scholar
• LasicDDNovel applications of liposomesTrends Biotechnol1998163073219675915
   PubMed Web of Science ®Google Scholar
• SilvermanJAReynoldsLDeitcherSRPharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemiaJ Clin Pharmacol2013531139114523907766
   PubMed Web of Science ®Google Scholar
• MoenMDLyseng-WilliamsonKAScottLJLiposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infectionsDrugs20096936139219275278
   PubMed Web of Science ®Google Scholar
• NastiTHKhanMAOwaisMEnhanced efficacy of pH sensitive nystatin liposomes against Cryptococcus neoformans in murine modelJ Antimicrob Chemother20065734935216368700
   PubMed Web of Science ®Google Scholar
• DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev19995169174310581328
   PubMed Web of Science ®Google Scholar
• LaoJMadaniJPuértolasTLiposomal doxorubicin in the treatment of breast cancer patients: a reviewJ Drug Deliv2013201345640923634302
   PubMedGoogle Scholar
• RafiyathSMRasulMLeeBWeiGLambaGLiuDComparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisExp Hematol Oncol201211023210520
   PubMedGoogle Scholar
• PisanoCCecereSCDi NapoliMClinical trials with pegylated liposomal doxorubicin in the treatment of ovarian cancerJ Drug Deliv2013201389814623577259
   PubMedGoogle Scholar
• GordonANGranaiCORosePGPhase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancerJ Clin Oncol2000183093310010963637
   PubMed Web of Science ®Google Scholar
• KatsumataNFujiwaraYKamuraTPhase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a phase II study of the Japanese Gynecologic Oncology GroupJpn J Clin Oncol20083877778518927230
   PubMed Web of Science ®Google Scholar
• MarkmanMKennedyAWebsterKPetersonGKulpBBelinsonJPhase 2 trial of liposomal doxorubicin (40 mg/m2) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneumGynecol Oncol20007836937210985896
   PubMed Web of Science ®Google Scholar
• LotemMHubertALyassOSkin toxic effects of polyethylene glycol-coated liposomal doxorubicinArch Dermatol20001361475148011115157
   PubMed Web of Science ®Google Scholar
• AlbertsDSMuggiaFMCarmichaelJEfficacy and safety of liposomal anthracyclines in phase I/II clinical trialsSemin Oncol200431539015717738
   PubMed Web of Science ®Google Scholar
• GabizonAALiposomal anthracyclinesHematol Oncol Clin North Am199484314508040147
   PubMed Web of Science ®Google Scholar
• Von HoffDDLayardMWBasaPRisk factors for doxorubicin-induced congestive heart failureAnn Intern Med197991710717496103
   PubMed Web of Science ®Google Scholar
• BatistGRamakrishnanGRaoCSReduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancerJ Clin Oncol2001191444145411230490
   PubMed Web of Science ®Google Scholar
• O’BrienMEWiglerNInbarMReduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancerAnn Oncol20041544044914998846
   PubMed Web of Science ®Google Scholar
• GabizonAALyassOBerryGJWildgustMCardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignanciesCancer Invest20042266366915581046
   PubMed Web of Science ®Google Scholar
• MustafaMHDecreased risk of cardiotoxicity with long-term use of Doxil/Caelyx at high lifetime cumulative doses in patients with AIDS-related Kaposi/Es sarcoma (KS)Poster presented at: ASCO Annual Meeting 2001May 12–15, 2001San Francisco, CA
   Google Scholar
• AndreopoulouEGaiottiDKimEPegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerAnn Oncol20071871672117301073
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev20116313113520304019
   PubMed Web of Science ®Google Scholar
• HashizumeHBalukPMorikawaSOpenings between defective endothelial cells explain tumor vessel leakinessAm J Pathol20001561363138010751361
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res199555375237567641188
   PubMed Web of Science ®Google Scholar
• BrownSKhanDRThe treatment of breast cancer using liposome technologyJ Drug Deliv2012201221296522506119
   PubMedGoogle Scholar
• RobertsWGDelaatJNaganeMHuangSCaveneeWKPaladeGEHost microvasculature influence on tumor vascular morphology and endothelial gene expressionAm J Pathol1998153123912489777955
   PubMed Web of Science ®Google Scholar
• O’NealDPHirschLRHalasNJPayneJDWestJLPhoto-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Lett200420917117615159019
   PubMed Web of Science ®Google Scholar
• WoodleMCMatthayKKNewmanMSVersatility in lipid compositions showing prolonged circulation with sterically stabilized liposomesBiochim Biophys Acta199211051932001586658
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHBarenholzYPharmacokinetics of PEGylated liposomal doxorubicin: review of animal and human studiesClin Pharmacokinet20034241943612739982
   PubMed Web of Science ®Google Scholar
• IshidaTHarashimaHKiwadaHLiposome clearanceBiosci Rep20022219722412428901
   PubMed Web of Science ®Google Scholar
• SempleSCHarasymTOClowKAAnsellSMKlimukSKHopeMJImmunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acidJ Pharmacol Exp Ther20053121020102615525796
   PubMed Web of Science ®Google Scholar
• GabizonAAShmeedaHZalipskySPros and cons of the liposome platform in cancer drug targetingJ Liposome Res20061617518316952872
   PubMed Web of Science ®Google Scholar
• DaemenTHofstedeGTen KateMTBakker-WoudenbergIAScherphofGLLiposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophagesInt J Cancer1995617167217768646
   PubMed Web of Science ®Google Scholar
• JulianoRLStampDPharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycinBiochem Pharmacol1978272127619903
   PubMed Web of Science ®Google Scholar
• GabizonAAStealth liposomes and tumor targeting: one step further in the quest for the magic bulletClin Cancer Res2001722322511234871
   PubMed Web of Science ®Google Scholar
• Bedu-AddoFKTangPXuYHuangLEffects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug deliveryPharm Res1996137107178860425
   PubMed Web of Science ®Google Scholar
• PhotosPJBacakovaLDischerBBatesFSDischerDEPolymer vesicles in vivo: correlations with PEG molecular weightJ Control Release20039032333412880699
   PubMed Web of Science ®Google Scholar
• HarrisJMPoly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical ApplicationsNew YorkPlenum1992
   Google Scholar
• GrefRDombAQuellecPThe controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Deliv Rev19951621523325170183
   PubMed Web of Science ®Google Scholar
• MoghimiSMHedemanHMuirISIllumLDavisSSAn investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleenBiochim Biophys Acta199311572332408323953
   PubMed Web of Science ®Google Scholar
• HarrisJMMartinNEModiMPEGylation: a novel process for modifying pharmacokineticsClin Pharmacokinet20014053955111510630
   PubMed Web of Science ®Google Scholar
• WuHRamanathanRKZamboniBAPopulation pharmacokinetics of PEGylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesJ Clin Pharmacol20115218019421233302
   PubMed Web of Science ®Google Scholar
• HeyesJHallKTailorVLenzRMacLachlanISynthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug deliveryJ Control Release200611228029016603272
   PubMed Web of Science ®Google Scholar
• AllenTMLiposomes. Opportunities in drug deliveryDrugs1997548149361956
   PubMed Web of Science ®Google Scholar
• GabizonAAPEGylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapyCancer Invest20011942443611405181
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
   PubMed Web of Science ®Google Scholar
• AndresenTLJensenSSJørgensenKAdvanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug releaseProg Lipid Res200544689715748655
   PubMed Web of Science ®Google Scholar
• BarenholzYLiposome application: problems and prospectsCurr Opin Colloid Interface Sci201166677
   Google Scholar
• BandakSGorenDHorowitzATzemachDGabizonAPharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsAnticancer Drugs19991091192010630359
   PubMed Web of Science ®Google Scholar
• AsaiTOkuNAngiogenic vessel-targeting DDS by liposomalized oligopeptidesMethods Mol Biol201060533534720072892
   PubMedGoogle Scholar
• GabizonATzemachDGorinJImproved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor modelsCancer Chemother Pharmacol201066435219779718
   PubMed Web of Science ®Google Scholar
• GargATisdaleAWHaidariEKokkoliETargeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptideInt J Pharm200936620121018835580
   PubMed Web of Science ®Google Scholar
• VingerhoedsMH1HaismaHJvan MuijenMvan de RijtRBCrommelinDJStormGA new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugsFEBS Lett19933364854908282116
   PubMed Web of Science ®Google Scholar
• NobleGTStefanickJFAshleyJDKiziltepeTBilgicerBLigand-targeted liposome design: challenges and fundamental considerationsTrends Biotechnol201432324524210498
   PubMed Web of Science ®Google Scholar
• FanciullinoRGiacomettiSAubertCDevelopment of stealth liposome formulation of 2′-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo studyPharm Res2005222051205716222443
   PubMed Web of Science ®Google Scholar
• SeniorJHTrimbleKRMaskieviczRInteraction of positively charged liposomes with blood: implications for their application in vivoBiochim Biophys Acta199110701731791751523
   PubMed Web of Science ®Google Scholar
• ZhaoWZhuangSQiXRComparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInt J Nanomedicine201163087309822163162
   PubMed Web of Science ®Google Scholar
• HarashimaHMatsuoHKiwadaHIdentification of proteins mediating clearance of liposomes using a liver perfusion systemAdv Drug Delivery Rev1998326179
   Web of Science ®Google Scholar
• MillerCRBondurantBMcLeanSDMcGovernKAO’BrienDFLiposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomesBiochemistry19983712875128839737866
   PubMed Web of Science ®Google Scholar
• CullisPRChonnASempleSCInteractions of liposome and lipid-based carrier systems with blood proteins: relation to clearance behavior in vivoAdv Drug Delivery Rev199832317
   PubMed Web of Science ®Google Scholar
• CampbellPIToxicity of some charged lipids used in liposome preparationsCytobios19833721266851664
   PubMedGoogle Scholar
• AllisonAGGregoriadisGLiposomes as immunological adjuvantsNature19742522524424229
   PubMed Web of Science ®Google Scholar
• NakanishiTKunisawaJHayashiAPositively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteinsJ Control Release19996123324010469918
   PubMed Web of Science ®Google Scholar
• AfrinFRajeshRAnamKGopinathMPalSAliNCharacterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c miceInfect Immun2002706697670612438344
   PubMed Web of Science ®Google Scholar
• BadieeAJaafariMRKhamesipourAThe role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63)Exp Parasitol200912136236919211022
   PubMed Web of Science ®Google Scholar
• González-RodríguezMLRabascoAMCharged liposomes as carriers to enhance the permeation through the skinExpert Opin Drug Deliv2011885787121557706
   PubMed Web of Science ®Google Scholar
• OgisoTYamaguchiTIwakiMTaninoTMiyakeYEffect of positively and negatively charged liposomes on skin permeation of drugsDrug Target200194959
   PubMed Web of Science ®Google Scholar
• FelgnerPLGadekTRHolmMLipofection: a highly efficient lipid-mediated DNA transfection procedureProc Natl Acad Sci U S A198784741374172823261
   PubMed Web of Science ®Google Scholar
• BombelliCCaraccioloGDi ProfioPInclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: correlation between physicochemical and biological features of the complexesJ Med Chem2005484882489116033268
   PubMed Web of Science ®Google Scholar
• StriethSEichhornMESauerBNeovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculatureInt J Cancer200411011712415054876
   PubMed Web of Science ®Google Scholar
• WuJLeeALuYLeeRJVascular targeting of doxorubicin using cationic liposomesInt J Pharma2007337329335
   PubMed Web of Science ®Google Scholar
• CampbellRBFukumuraDBrownEBCationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumorsCancer Res2002626831683612460895
   PubMed Web of Science ®Google Scholar
• CampbellRBYingBKuestersGMHemphillRFighting cancer: from the bench to bedside using second generation cationic liposomal therapeuticsJ Pharm Sci20099841142918563780
   PubMed Web of Science ®Google Scholar
• SchnyderAHuwylerJDrug transport to brain with targeted liposomesNeuroRx200529910715717061
   PubMedGoogle Scholar
• KrasniciSWernerAEichhornMEEffect of the surface charge of liposomes on their uptake by angiogenic tumor vesselsInt J Cancer200310556156712712451
   PubMed Web of Science ®Google Scholar
• StamatatosLLeventisRZuckermannMJSilviusJRInteractions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranesBiochemistry198827391739253415963
   PubMed Web of Science ®Google Scholar
• LitzingerDCBrownJMWalaIFate of cationic liposomes and their complex with oligonucleotide in vivoBiochim Biophys Acta199612811391498664312
   PubMed Web of Science ®Google Scholar
• McLeanJWFoxEABalukPOrgan-specific endothelial cell uptake of cationic liposome-DNA complexes in miceAm J Physiol1997273H387H4049249514
   PubMed Web of Science ®Google Scholar
• DassCRImproving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculatureInt J Pharm200326711214602379
   PubMedGoogle Scholar
• MeyerOKirpotinDHongKCationic liposomes coated with polyethylene glycol as carriers for oligonucleotidesJ Biol Chem199827315621156279624154
   PubMed Web of Science ®Google Scholar
• GurselIGurselMIshiiKJKlinmanDMSterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotidesJ Immunol20011673324332811544321
   PubMed Web of Science ®Google Scholar
• Skupin-MrugalskaPPiskorzJGoslinskiTMielcarekJKonopkaKDüzgüneşNCurrent status of liposomal porphyrinoid photosensitizersDrug Discov Today20131877678423591149
   PubMed Web of Science ®Google Scholar
• MolinariABombelliCManninoSm-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategyInt J Cancer20071211149115517471562
   PubMed Web of Science ®Google Scholar
• BombelliCStringaroABorocciSEfficiency of liposomes in the delivery of a photosensitizer controlled by the stereochemistry of a gemini surfactant componentMol Pharm2010713013719929006
   PubMedGoogle Scholar
• TorchilinVMultifunctional and stimuli-sensitive pharmaceutical nanocarriersEur J Pharm Biopharm20097143144418977297
   PubMed Web of Science ®Google Scholar
• PercheFTorchilinVPRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingJ Drug Deliv2013201370526523533772
   PubMedGoogle Scholar
• GullinoPMGranthamFHSmithSHHaggertyACModifications of the acid-base status of the internal milieu of tumorsJ Natl Cancer Inst1965348578694284033
   PubMedGoogle Scholar
• SimõesSMoreiraJNFonsecaCDüzgüneşNde LimaMCOn the formulation of pH-sensitive liposomes with long circulation timesAdv Drug Deliv Rev20045694796515066754
   PubMed Web of Science ®Google Scholar
• Caldeira de Araújo LopesSVinícius Melo NovaisMSalviano TeixeiraCPreparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acidBiomed Res Int2013201346714723984367
   PubMed Web of Science ®Google Scholar
• OngWYangYCrucianoACMcCarleyRLRedox-triggered contents release from liposomesJ Am Chem Soc2008130147391474418841890
   PubMed Web of Science ®Google Scholar
• YatvinMBWeinsteinJNDennisWHBlumenthalRDesign of liposomes for enhanced local release of drugs by hyperthermiaScience197820212901293364652
   PubMed Web of Science ®Google Scholar
• NeedhamDDewhirstMWThe development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumorsAdv Drug Deliv Rev20015328530511744173
   PubMed Web of Science ®Google Scholar
• LiLten HagenTLSchipperDTriggered content release from optimized stealth thermosensitive liposomes using mild hyperthermiaJ Control Release201014327427920074595
   PubMed Web of Science ®Google Scholar
• KongGAnyarambhatlaGPetrosWPEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseCancer Res2000606950695711156395
   PubMed Web of Science ®Google Scholar
• ThanouMGedroycWMRI-guided focused ultrasound as a new method of drug deliveryJ Drug Deliv2013201361619723738076
   PubMedGoogle Scholar
• EvansENeedhamDPhysical properties of surfactant bilayer membranes: thermal transitions, elasticity, rigidity, cohesion, and colloidal interactionsJ Phys Chem19879142194228
   Web of Science ®Google Scholar
• KonoKThermosensitive polymer-modified liposomesAdv Drug Deliv Rev20015330731911744174
   PubMed Web of Science ®Google Scholar
• GasselhuberADreherMRNegussieAWoodBJRattayFHaemmerichDMathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablationInt J Hyperthermia20102649951320377363
   PubMed Web of Science ®Google Scholar
• PoonRTBorysNLyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancerExpert Opin Pharmacother20091033334319236203
   PubMed Web of Science ®Google Scholar
• DromiSFrenkelVLukAPulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effectClin Cancer Res2007132722272717473205
   PubMed Web of Science ®Google Scholar
• HauckMLLaRueSMPetrosWPPhase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumorsClin Cancer Res2006124004401016818699
   PubMed Web of Science ®Google Scholar
• KheirolomoomALaiCYTamSMComplete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermiaJ Control Release201317226627323994755
   PubMed Web of Science ®Google Scholar
• WangLSChuangMCHoJANanotheranostics – a review of recent publicationsInt J Nanomedicine201274679469522956869
   PubMed Web of Science ®Google Scholar
• SumerBGaoJTheranostic nanomedicine for cancerNanomedicine (Lond)2008337140
   Web of Science ®Google Scholar
• DevezaLChoiJYangFTherapeutic angiogenesis for treating cardiovascular diseasesTheranostics2012280181422916079
   PubMed Web of Science ®Google Scholar
• JanibSMMosesASMacKayJAImaging and drug delivery using theranostic nanoparticlesAdv Drug Deliv Rev201021052106320709124
   PubMedGoogle Scholar
• YuMKParkJJonSTargeting strategies for multifunctional nanoparticles in cancer imaging and therapyTheranostics2012234422272217
   PubMed Web of Science ®Google Scholar
• XieJLeeSChenXNanoparticle-based theranostic agentsAdv Drug Deliv Rev2010621064107920691229
   PubMed Web of Science ®Google Scholar
• YeYChenXIntegrin targeting for tumor optical imagingTheranostics2011110212621546996
   PubMed Web of Science ®Google Scholar
• Al-JamalWTKostarelosKLiposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applicationsNanomedicine (Lond)20072859817716195
   PubMed Web of Science ®Google Scholar
• Al-JamalWTKostarelosKLiposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicineAcc Chem Res2011441094110421812415
   PubMed Web of Science ®Google Scholar
• NieYJiLDingHCholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterizationTheranostics201221092110323227125
   PubMed Web of Science ®Google Scholar
• LeungSJRomanowskiMLight-activated content release from liposomesTheranostics201221020103623139729
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov2005414516015688077
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes – improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A19918811460114641763060
   PubMed Web of Science ®Google Scholar
• Al-JamalWTAl-JamalKTTianBLipid-quantum dot bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivoACS Nano2008240841819206564
   PubMed Web of Science ®Google Scholar
• SoenenSJVande VeldeGKetkar-AtreAHimmelreichUDe CuyperMMagnetoliposomes as magnetic resonance imaging contrast agentsWiley Interdiscip Rev Nanomed Nanobiotechnol2011319721125363747
   PubMed Web of Science ®Google Scholar
• KamalyNMillerADParamagnetic liposome nanoparticles for cellular and tumour imagingInt J Mol Sci2010111759177620480040
   PubMed Web of Science ®Google Scholar
• LiSGoinsBZhangLBaoANovel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imagingBioconjug Chem2012231322133222577859
   PubMed Web of Science ®Google Scholar
• MuthuMSKulkarniSARajuAFengSSTheranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dotsBiomaterials2012333494350122306020
   PubMed Web of Science ®Google Scholar
• WenCJZhangLWAl-SuwayehSAYenTCFangJYTheranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimagingInt J Nanomedicine201271599161122619515
   PubMed Web of Science ®Google Scholar
• WenCJSungCTAljuffaliIAHuangYJFangJYNanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomesNanotechnology20132432510123867977
   PubMed Web of Science ®Google Scholar
• SmithBLyakhovILoomisKHyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)J Control Release201115318719421501640
   PubMed Web of Science ®Google Scholar
• LöfblomJFeldwischJTolmachevVCarlssonJStåhlSFrejdFYAffibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applicationsFEBS Lett20105842670168020388508
   PubMed Web of Science ®Google Scholar
• SvensonSTheranostics: are we there yet?Mol Pharm20131084885623379301
   PubMed Web of Science ®Google Scholar
• BarenholzYDoxil® – the first FDA-approved nano-drug: lessons learnedJ Control Release201216011713422484195
   PubMed Web of Science ®Google Scholar
• ChangHIYehMKClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyInt J Nanomedicine20127496022275822
   PubMed Web of Science ®Google Scholar
• MrossKNiemannBMassingUPharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose studyCancer Chemother Pharmacol20045451452415322827
   PubMed Web of Science ®Google Scholar
• StegmannTMorseltHWBooyFPvan BreemenJFScherphofGWilschutJFunctional reconstitution of influenza virus envelopesEMBO J19876265126593678202
   PubMed Web of Science ®Google Scholar
• GlückRMischlerRBrantschenSJustMAlthausBCryzSJJrImmunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis AJ Clin Invest199290249124951334977
   PubMed Web of Science ®Google Scholar
• ShajiJPatoleVProtein and peptide drug delivery: oral approachesIndian J Pharm Sci20087026927720046732
   PubMed Web of Science ®Google Scholar
• LöhrJMHaasSLBechsteinWOCationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialAnn Oncol2012231214122221896540
   PubMed Web of Science ®Google Scholar
• WhiteSCLoriganPMargisonGPPhase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBr J Cancer20069582282816969346
   PubMed Web of Science ®Google Scholar
• BooserDJEstevaFJRiveraEPhase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancerCancer Chemother Pharmacol2002506812111105
   PubMed Web of Science ®Google Scholar
• WagnerVDullaartABockAKZweckAThe emerging nanomedicine landscapeNat Biotechnol2006241211121817033654
   PubMed Web of Science ®Google Scholar
• BawaRNanoparticle-based therapeutics in humans: a surveyNLB20085135155
   Google Scholar
• FarajiAHWipfPNanoparticles in cellular drug deliveryBioorg Med Chem2009172950296219299149
   PubMed Web of Science ®Google Scholar
• Sigma-Tau Pharmaceuticals, Inc – Producs (Website) Available from: http://www.sigmatau.com/products/abelcet_rx.aspAccessed Sep 04, 2013
   Google Scholar
• Ambisome (amphotericin B) liposome for injection (Website) Available from: http://www.ambisome.com/Accessed Sep 03, 2013
   Google Scholar
• TollemarJRingdenOLipid formulations of amphotericin B. Less toxicity but at what economic cost?Drug Saf1995132072188573294
   PubMed Web of Science ®Google Scholar
• Samaritan Pharmaceuticals (Website) Available from: http://www.samaritanpharma.com/amphocil/Accessed Sep 03, 2013
   Google Scholar
• GrieseNBlaschkeGBoosJHempelGDetermination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresisJ Chromatogr A200297937938812498269
   PubMed Web of Science ®Google Scholar
• DaunoXome (Website) Available from: http://daunoxome.com/Accessed Sep 05, 2013
   Google Scholar
• BaoAGoinsBKlipperRNegreteGPhillipsWTDirect 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studiesJ Pharmacol Exp Ther200430841942514610219
   PubMed Web of Science ®Google Scholar
• Doxil (Website) Available from: http://www.doxil.com/Accessed Sep 05, 2013
   Google Scholar
• Visudyne (Website) Available from: http://www.visudyne.com/Accessed Sep 05, 2013
   Google Scholar
• MuggiaFMLiposomal encapsulated anthracyclines: new therapeutic horizonsCurr Oncol Rep2001315616211177748
   PubMedGoogle Scholar
• TLC – Product (Website) Cited2011331 Available from: http://www.tlcbio.com/en/product.html
   Google Scholar
• Crucell (Website) Available from: http://www.crucell.com/ProductsAccessed Oct 2, 2013
   Google Scholar
• PatilSDBurgessDJLiposomes, design and manufacturingBurgessDJInjectable Dispersed Systems: Formulation, Processing and Performance (Drugs and The Pharmaceutical Sciences Series)New YorkMarcel Dekker2005249303
   Google Scholar
• Pacira Pharmaceuticals, INC – Produtcs (Website) Cited201393 Aivable from: http://www.pacira.com/products/depodur.php
   Google Scholar
• NCT00002742. Antifungal therapy for fever and neutropenia in patients receiving treatment for hematologic cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• MoribeKMaruyamaKPharmaceutical design of the liposomal antimicrobial agents for infectious diseaseCurr Pharm Des2002844145412069381
   PubMed Web of Science ®Google Scholar
• NCT00364676. Study of Vinorelbine liposomes injection for advanced solid tumors, non Hodgkin’s lymphoma or Hodgkin’s disease (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Talon Therapeutics, Inc. (Website)Talon product portfolio Available from: http://www.talontx.com/pipeline.phpAccessed Sep 03, 2013
   Google Scholar
• NCT01652859. An bioequivalence study to compare two 2 mg/mL liposomal Amphotericin B injections in healthy subjects (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00043199. A safety and effectiveness study of aroplatin in patients with advanced colorectal cancer resistant to standard therapies (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• LuCPerez-SolerRPiperdiBPhase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheliomaJ Clin Oncol2005233495350115908659
   PubMed Web of Science ®Google Scholar
• DragovichTMendelsonDKurtinSRichardsonKVon HoffDHoosAA Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancerCancer Chemother Pharmacol20065875976416847673
   PubMed Web of Science ®Google Scholar
• NCT01041235. Safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed previous therapies (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Azaya Therapeutics Products (Website) Available from: http://www.azayatherapeutics.com/about-us/productsAccessed Sep 06, 2013
   Google Scholar
• NCT00005969. Liposomal tretinoin in treating patients with recurrent or refractory Hodgkin’s disease (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• ManconiMSinicoCValentiDLoyGFaddaAMNiosomes as carriers for tretinoin-Preparation and propertiesInt J Pharm20023423724811839454
   PubMedGoogle Scholar
• AlekuMSchulzPKeilOAtu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progressionCancer Res200868978819047158
   PubMed Web of Science ®Google Scholar
• LiLShenYOvercoming obstacles to develop effective and safe siRNA therapeuticsExpert Opin Biol Ther2009960961919392577
   PubMed Web of Science ®Google Scholar
• Silence Therapeutics (Website) Available from: http://silence-therapeutics.com/pipeline/preclinical-development/Accessed Sep 06, 2013
   Google Scholar
• NCT00245297. Study of the efficacy of human recombinant factor VIII (Kogenate FS) reconstituted in pegylated liposomes (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• PowellJNugentDHarrisonJSafety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia AJ Thromb Haemost2008627728318039351
   PubMed Web of Science ®Google Scholar
• NCT01159028. Clinical trial of L-Grb-2 antisense oligonucleotide in CML, AML, ALL and MDS (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Bio-Path Holdings, Inc (Website) Available from: http://www.biopathholdings.com/pdf/factsheetv1.pdfAccessed Sep 06, 2013
   Google Scholar
• NCT00765973. Topotecan liposomes injection for small cell lung cancer (SCLC), ovarian cancer and other advanced solid tumors (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00361842. Multicenter study Of CPX-1 (Irinotecan HCl: Floxuridine) liposome injection in patients with advanced colorectal cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• MayerLDJanoffASOptimizing combination chemotherapy by controlling drug ratiosMol Interv2007721622317827442
   PubMed Web of Science ®Google Scholar
• NCT00875693. A novel sequential treatment of salvage and reduced intensity conditioning (RIC) chemotherapy for allogeneic stem-cell transplantation (SCT) for primary refractory and relapsed acute myelogenous leukemia (AML) (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00968604. C-VISA BikDD: liposome in advanced pancreatic cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• XieXXiaWLiZTargeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging modelsCancer Cell2007125217613436
   PubMed Web of Science ®Google Scholar
• MatsumuraYPreclinical and clinical studies of anticancer drug-incorporated polymeric micellesJ Drug Target20071550751717671897
   PubMed Web of Science ®Google Scholar
• ThurstonGMcLeanJWRizenMBalukPHaskellAMurphyTJCationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in miceJ Clin Invest1998101140114139525983
   PubMed Web of Science ®Google Scholar
• NCT00364143. Safety study of IHL-305 (Irinotecan Liposome Injection) to treat advanced solid tumors (ClinicalTrial). ClinicalTrials.gov.
   Google Scholar
• NCT00059605. Phase I study of IV DOTAP: cholesterol-Fus1 in non-small-cell lung cancer. (ClinicalTrial). ClinicalTrials.gov.
   Google Scholar
• NCT00860522. JVRS-100 for the treatment of patients with relapsed or refractory leukemia (ClinicalTrial). ClinicalTrials.gov.
   Google Scholar
• ChangSWarnerJLiangLFairmanJA novel vaccine adjuvant for recombinant flu antigensBiologicals20093714114719285425
   PubMed Web of Science ®Google Scholar
• NCT00271063. Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia (ClinicalTrial). ClinicalTrials.gov.
   Google Scholar
• BooserDJEstevaFJRiveraEPhase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancerCancer Chemother Pharmacol2002506812111105
   PubMed Web of Science ®Google Scholar
• Neopharm, IncProducts – Neopharm (Website) Available from: www.neopharm.com/products/Accessed Sep 06, 2013
   Google Scholar
• NCT00024492. Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01190982. Efficacy and safety study of LEP-ETU to treat metastatic breast cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• ZhangJAAnyarambhatlaGMaLDevelopment and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulationEur J Pharm Biopharm20055917718715567316
   PubMed Web of Science ®Google Scholar
• NCT00024648. Study to determine maximum tolerated dose of LErafAON combined with radiotherapy in patients with advanced malignancies (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00035867. Study of TLK199 HCl liposomes for injection in myelodysplastic syndrome (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• RudinCMMarshallJLHuangCHDelivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumorsClin Cancer Res2004107244777251
   Web of Science ®Google Scholar
• NCT00104754. Liposomal SN-38 in treating patients with small cell lung cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• ZhangJAXuanTParmarMDevelopment and characterization of a novel liposome-based formulation of SN-38Int J Pharm20042709310714726126
   PubMed Web of Science ®Google Scholar
• NCT01159028. Clinical trial of L-Grb-2 antisense oligonucleotide in CML, AML, ALL and MDS (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• TariAMGutiérrez-PuenteYMonacoGLiposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenograftsInt J Oncol2007311243125017912453
   PubMed Web of Science ®Google Scholar
• FantiniMGianniLSantelmoCLipoplatin treatment in lung and breast cancerChemother Res Pract2011201112519222295201
   PubMedGoogle Scholar
• StathopoulosGPBoulikasTVougioukaMPharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I studyOncol Rep20051358959515756428
   PubMed Web of Science ®Google Scholar
• FarhatFSTemrazSKattanJA phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancerClin Breast Cancer20111138438921993011
   PubMed Web of Science ®Google Scholar
• NCT00739466. Biorest Liposomal Alendronate With Stenting sTudy (BLAST) (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00747474. Phase i study of intravenous LipotecanR (TLC388 HCl for Injection) in patients with advanced solid tumors (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• HuangZRHuaSCYangYLFangJYDevelopment and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsionActa Pharmacol Sin2008291094110218718178
   PubMed Web of Science ®Google Scholar
• NCT01052142. Safety study of a liposomal vaccine to treat malignant melanoma (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• HerringsonTPAltinJGConvenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored moleculesJ Control Release200913922923819595724
   PubMed Web of Science ®Google Scholar
• NCT00053716. Prostaglandin E1 (Liprostin) treatment with lower limb angioplasty for peripheral arterial occlusive disease (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00631631. L-MTP-PE for high-risk osteosarcoma (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• JainVVyasSPKohliDVWell-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivativesNanomedicine2009533434419523433
   PubMed Web of Science ®Google Scholar
• NCT00144963. Liposomal Vincristine plus Dexamethasone in patients with relapsed or refractory acute lymphoblastic leukemia (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00964080. Study of MBP-426 in Patients with second line gastric, gastroesophageal, or esophageal adenocarcinoma (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Mebiopharm – Product and Technologies (Website) Available from: http://www.mebiopharm.com/english/pro.htmlAccessed Sep 06, 2013
   Google Scholar
• HamaguchiTMatsumuraYNakanishiYMuroKYamadaYShimadaYAntitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenograftsCancer Sci20049560861315245599
   PubMed Web of Science ®Google Scholar
• NCT00294996. Trial of Myocet in Metastatic Breast Cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01039103. Nanocort in acute exacerbation of relapsing-remitting Multiple Sclerosis (MS). (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• ChowT-HLinY-YHwangJ-JWangH-ETsengY-LPangVFTherapeutic efficacy evaluation of 111 in-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imagingJ Nucl Med2009502073208119949027
   PubMed Web of Science ®Google Scholar
• NCT00038207. Liposomal Vincristine for pediatric and adolescent patients with relapsed malignancies (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• GelmonKATolcherADiabARPhase I study of liposomal vincristineJ Clin Oncol19991769770510080616
   PubMed Web of Science ®Google Scholar
• NCT00046787. Efficacy and safety study of OSI-211 (Liposomal Lurtotecan) to treat recurrent small cell lung cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00940758. Phase I and pharmacokinetic study of biweekly PEP02 in mCRC refractory to 1st-line oxaliplatin base therapy (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01191775. A Study of PNT2258 in patients with advanced solid tumors (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01054547. Topical formulations of liposomal local anesthetics (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Bexion Pharmaceuticals (Website) Available from: http://www.bexionpharma.com/Accessed Sep 06, 2013
   Google Scholar
• QiXChuZMahllerYYStringerKFWitteDPCripeTPCancer-Selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C ProteinClin Cancer Res2009155840585119737950
   PubMed Web of Science ®Google Scholar
• WojtonJChuZMathsyarajaHSystemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against GlioblastomaMol Ther2013211517152523732993
   PubMed Web of Science ®Google Scholar
• NCT00177281. Safety study of S-CKD602 in patients with advanced malignancies. (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00157209. Phase IIb randomized controlled study of blp25 liposome vaccine for immunotherapy of non-small cell lung cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00617981. Phase 3 Study of ThermoDox with Radiofrequency Ablation (RFA) in treatment of Hepatocellular Carcinoma (HCC) (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Celsion Corporation (Website) Available from: http://celsion.com/docs/pipeline_overviewAccessed Sep 06, 2013
   Google Scholar
• NCT00927459. Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of liposomal siRNA in subjects with high cholesterol (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• RossiJJRNAi therapeutics: SNALPing siRNAs in vivoGene Ther20061358358417526070
   PubMed Web of Science ®Google Scholar
• Tekmira Pharmaceuticals Corporation-Products (Website) Available from: http://www.tekmirapharm.com/Programs/Products.aspAccessed Sep 06, 2013
   Google Scholar
• NCT00089180. T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• CafardiJAElmetsCAT4 endonuclease V: review and application to dermatologyExpert Opin Biol Ther2008882983818476794
   PubMed Web of Science ®Google Scholar
• NCT01050777. Efficacy of topical liposomal form of drugs in cutaneous leishmaniasis (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00764361. Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Nanotherapeutics – Products (Website) Available from: http://www.nanotherapeutics.com/?q=products_nanodoxAccessed Sep 06, 2013
   Google Scholar
• NCT00089180. T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• YaroshDKleinJO’ConnorAHawkJRafalEWolfPEffect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xenoderma pigmentosum study groupLancet200135792692911289350
   PubMed Web of Science ®Google Scholar
• NCT00709254. Study of single and multiple doses of inhaled AeroLEF (Liposome-Encapsulated Fentanyl) in healthy subjects (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00775138. A Study to Determine the Safety and Tolerability of Arikace™ Versus Placebo in Patients Who Have Bronchiectasis.
   Google Scholar
• NCT00492141. Aerosol L9-NC and temozolomide in ewing’s sarcoma (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00915187. Safety and immunogenicity study of intramuscular CCS/C-adjuvanted influenza vaccine in elderly (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00922363. Trial on the safety of a new liposomal adjuvant system, CAF01, when given with the tuberculosis subunit vaccine Ag85B-ESAT-6 as two injections with two months interval to healthy adult volunteers (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00460525. Phase II AMA-1 malaria vaccine FMP2.1/AS02A trial in mali (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00004806. Phase I Study of liposome-mediated gene transfer in patients with cystic fibrosis (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00533637. Taste and local tolerance study of NLA nasal spray in patients with allergic rhinitis (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Orexo AB – OX-NLA (Website) Available from: http://www.orexo.com/en/Portfolio/OX-NLA/Accessed Sep 05, 2013
   Google Scholar
• NCT00004471. Phase I pilot study of gene therapy for cystic fibrosis using cationic liposome mediated gene transfer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01095848. A phase I safety study of a cancer vaccine to treat HLA-a2 positive advanced stage ovarian, breast and prostate cancer (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT00004104. Vaccine therapy plus interleukin-2 with or without interferon alfa-2b in treating patients with stage III melanoma (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• NCT01073371. Anesthetic efficacy of liposomal prilocaine in maxillary infiltration anesthesia (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• Saia CeredaCMTofoliGRde Brito JuniorRBStability and local toxicity evaluation of a liposomal prilocaine formulationJ Liposome Res20081832933918991066
   PubMed Web of Science ®Google Scholar
• NCT01334892. L-CsA in the prevention of bronchiolitis obliterans syndrome (BOS) in lung transplant (LT) patients (Clinical Trial). ClinicalTrials.gov.
   Google Scholar
• BehrJZimmermannGBaumgartnerRLung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantationJ Aerosol Med Pulm Drug Deliv20092212113019422312
   PubMed Web of Science ®Google Scholar
• NCT00035867. Study of TLK199 HCl liposomes for injection in myelodysplastic syndrome (Clinical Trial). ClinicalTrials.gov.
   Google Scholar